The company NanoTech Pharma has been operating since 2009. The company is a manufacturer and developer of a number of pharmaceutical products and products, including the medical patch Nanoplast Forte. Therapeutic anesthetic anti-inflammatory Nanoplast forte is a new standard for the treatment of diseases of the musculoskeletal system. Detailed clinical studies based on evidence-based medicine have shown that the Nanoplast forte therapeutic patch has high efficacy and safety for both reliefs of acute conditions and course therapy for various diseases of the joints, spine, muscles and ligaments.

Osteoarthritis is one of the most common rheumatic diseases and has the greatest medical and social importance among all joint diseases. Despite the significant progress made in recent years in the treatment of osteoarthritis, the question of treatment tactics in the light of the efficacy and safety of the drugs used is still relevant. Of particular interest are methods of local therapy based on nanotechnology. Clinical studies have confirmed the high efficiency of the Nanoplast forte with minimal side effects. Nanoplast forte passed state registration in accordance with the legislation of the Russian Federation and is sold exclusively in pharmacies. The drug Nanoplast forte underwent a multicenter, double-blind, randomized, placebo-controlled clinical study of the efficacy and tolerability in patients with osteoarthritis of the knee joints in three specialized medical centers in Russia. In a general assessment of the effectiveness of treatment, a high effect of therapy was established - in 82% of patients, there was a significant improvement.


Nanoplast forte also underwent a multicenter, double-blind, randomized, placebo-controlled clinical trial at three specialized medical centers in the PRC. This study statistically reliably showed high efficacy (up to 95%) and safety of the drug in the treatment of osteoarthritis, osteochondrosis of the cervical and thoracic spine,  as well as closed injuries (bruises, sprains and muscles, reduced dislocations of the joints) of the musculoskeletal system. In the treatment of spinal osteochondrosis, Nanoplast forte is applied to the cervical, thoracic or lumbar spine depending on the type of disease and pain localization. To remove acute symptoms in treating spinal osteochondrosis, a medical patch is applied from 3 to 5 days. The course duration is 9 days. It is usually recommended to use a medical patch in the morning for 12 hours, but it is possible to use it overnight.

Among other indications for the purpose of the Nanoplast Forte plaster, degenerative intervertebral disc disease can be identified with the development of protrusions, intervertebral hernia, resulting in sciatica. Despite the fact that in the acute period of rheumatic diseases, local therapy is not indicated (as a rule, it is prescribed on the 3-5th day, when the inflammation subsides), Nanoplast Forte is irreplaceable in this period, as it is irreplaceable at other stages of the subacute or chronic course. Other indications for using Nanoplast Forte are post-traumatic changes of the musculoskeletal system since secondary osteoarthrosis develops after an injury, and the pain syndrome is very pronounced and may be complicated by the development of complex regional pain syndromes. Another area for applying Nanoplast Forte is the pathology of soft tissues (for example, fibromyalgia, myofascial syndrome), which occurs not only in rheumatic diseases.

The high-quality adhesive layer provides a reliable fastening of the patch and makes the use of the drug as comfortable as possible. The plaster is easily applied and removed from the skin, does not slip during use. Unlike other painkillers, Nanoplast forte not only relieves pain but also has a therapeutic anti-inflammatory effect, which has been clinically proven. Nanoplast forte accelerates the natural process of restoring damaged tissue.

The distribution company AMMA LLC is now responsible for wholesaling.